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BJD: onwards and upwards 
 
 
 
Medical publishing does not stand still and, to paraphrase the Greek philosopher Heraclitus of 
Ephesus, The o l  thi g that is o sta t is ha ge.  This is my first issue as BJD Editor, having taken 
on leadership of the journal from Alex Anstey on July 1st. I am delighted that Eleni Linos, Stanford 
University, California, and Neil Rajan, Newcastle University, UK have joined the BJD senior editorial 
team as Deputy Editors. 
While Editor of BJD from 2013 to 2019, Alex Anstey undertook a prodigious change process to 
ensure that BJD remains a top dermatology journal. Importantly, Alex started from first principles, 
asking the question What does the BJD sta d fo ? 1 A consensus position statement emerged, in 
which BJD strives to publish the highest quality research encompassing clinical trials, epidemiology, 
outcomes and qualitative research, and translational research that describes basic science of 
potential clinical relevance. 
Journal enhancements have flowed from the mission statement. The next step was to assemble a 
senior editorial team of stellar clinical academics for each journal section (take a look at the journal 
team on our website2). Our editorial team of section and associate editors increased in number from 
less than 20 to nearly 80 in a five year period (figure 1), with close to 1:1 gender balance and a wide 
geographical spread across the continents.3  
Once the team was in place, we moved onto considering how to add value to original articles for our 
readers and authors. Under Alex s leadership, most BJD original articles are accompanied by a plain 
language summary in English and Chinese, a commentary from an expert in the field, PowerPoint 
journal club slides and an author video (we now have a BJD YouTube channel4).  
As well as these innovations, Alex ensured that the fundamentals of the BJD remain sound. He 
created a Journal Handbook, ensuring that all journal processes are formalised and aligned with best 
practice as defined by the Committee on Publication Ethics. Alex recommended creation of a BJD 
Editorial Board Advisory Committee (EBAC) to strengthen journal oversight and to manage 
important areas such as appointment of our publisher and the BJD Editor. Prof John McGrath is 
current chair of EBAC, coordinating a set of world-leading dermatology clinical academics. The BJD is 
fortunate to receive their guidance.  
What will I champion as incoming editor? My priorities are to broaden the global reach of the 
journal and to enhance the BJD s a d as a top de atolog  jou al, acting as a hub for the highest 
quality skin research to help improve patient care. Working from sound fundamentals, the process 
of journal evolution will continue. I will focus on the quality of original articles within BJD s o e 
methodologies, with a particular emphasis on clinical trials that have the potential to change 
practice. The best clinical trial reports will benefit from a fast track review process to ensure 
publication in early view within a few days of submission. I myself will continue to be clinically- and 
research-active in the field of hidradenitis suppurativa, ensuring I retain empathy with authors and 
readers.  
Academics are an important part of the BJD community and part of the drive to maintain and 
improve our dermatology journal ranking is to support the careers of academics who publish in BJD, 
who are judged by their publication outputs. While BJD strives for excellence in its original articles, it 
must remain accessible to dermatology trainees. The BJD is ensuring this by creation of Editorial 
Trainee posts, initially in the UK and now internationally.5 Included in their role is supervision of our 
Image Gallery, providing a publication avenue for less experienced authors.      
Increasingly, clinical research needs active involvement from patient research partners. Patients are 
also direct beneficiaries of dermatology research, when making informed choices about their own 
care. In the conte t that the BJD issio  state e t is To pu lish the highest ualit  de atolog  
esea h to i p o e patie t a e  patie ts ill e o e o e di e tl  i ol ed i  the jou al.6 
There are many stakeholders who are important to BJD. Our success is built on the support of you, 
our reader, and by colleagues submitting their best work to BJD. Quality assurance of the work we 
publish is provided by our selfless reviewers, supported now by a team of BJD statisticians. BJD is a 
clinical journal and so we will continue to assist clinicians by publishing high quality guidelines, 
including those produced by British Association of Dermatology and, increasingly, guidelines from 
around the world that meet BJD quality criteria.7  
Returning to the theme of change, Plus ça change, plus est la même chose.  Under my editorship, 
the mantra regarding our original articles will remain: quality, quality, quality.    
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Legend: BJD Editorial Team meeting, July 2018 
